Violet Therapeutics

Violet Therapeutics is a preclinical-stage biotechnology company headquartered in Somerville, Massachusetts, developing first-in-class therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's by targeting EphB3 inhibitors to reduce neuroinflammation. The company raised a $4.75M seed extension in May 2026 to advance its novel therapeutic for synaptic preservation and repair.